<DOC>
	<DOCNO>NCT01803477</DOCNO>
	<brief_summary>The purpose study determine new vehicle formulation contain ingenol mebutate safe effective Picato速 gel 0.05 % ( 's current vehicle formulation ) apply AK lesion forearm two consecutive day .</brief_summary>
	<brief_title>Safety Dose Finding Study New Vehicle Formulations Containing Ingenol Mebutate Treat Actinic Keratosis Forearm</brief_title>
	<detailed_description>This study run 2 part . The first part involve apply escalate concentration new vehicle formulation contain ingenol mebutate AKs forearm . Reactions safety compare Picato速 ( register market ingenol mebutate gel ) ascertain new vehicle formulation least safe effective Picato速 . The purpose part 2 select concentration `` new formulation '' produce , good response , Picato速 similar good safety profile .</detailed_description>
	<mesh_term>Keratosis</mesh_term>
	<mesh_term>Keratosis , Actinic</mesh_term>
	<criteria>Must male female least 18 year age . Female patient must nonchildbearing potential childbearing potential negative serum urine pregnancy test use effective contraception . Ability provide inform consent . location select treatment area within 5cm incompletely heal wound within 5cm suspect basal cell carcinoma squamous cell carcinoma undergone Cosmetic therapeutic procedure within 2cm selected treatment area 2 week prior treatment visit presence sunburn within select treatment area use acidcontaining therapeutic product within 2cm selected treatment area 2 week prior treatment visit previous enrolment clinical trial prior treatment ingenol mebutate forearm use topical moisturisers/creams/lotions , artificial tanner topical steroid within 2cm select treatment area 2 week prior treatment visit treatment immunomodulators , interferon/interferon inducer systemic medication suppress immune system within 4 week treatment visit treatment 5FU , imiquimod , diclofenac , photodynamic therapy within 2 cm treatment area 8 week prior treatment visit use systemic retinoids currently participate clinical trial female pregnant breastfeed know suspected able comply requirement protocol provide consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>